Breaking News Instant updates and real-time market news.

NVS

Novartis

$70.64

-1.9 (-2.62%)

05:31
11/21/16
11/21
05:31
11/21/16
05:31

Novartis says GOLD recommends broad use of dual bronchodilators to treat COPD

Novartis welcomes the publication of the Global Initiative for Chronic Obstructive Lung Disease, or GOLD, 2017 report. For the first time, GOLD has recommended the first-line use of dual bronchodilators, such as Ultibro Breezhaler 110/50 mcg, in the treatment of the majority of symptomatic chronic obstructive pulmonary disease, or COPD, patients, regardless of their exacerbation risk. The GOLD 2017 report is a tool to help health care professionals worldwide implement effective COPD management programs. Significantly, the use of inhaled steroid-containing combination therapies is now only recommended in a minority of patients, following dual bronchodilator treatment.

  • 03

    Dec

NVS Novartis
$70.64

-1.9 (-2.62%)

10/20/16
JANY
10/20/16
NO CHANGE
Target $1.5
JANY
Neutral
Cerulean cash infusion gives chance to execute on programs, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said Cerulean's (CERU) collaboration with Novartis (NVS), which comes with a "modest" $5M upfront payment, and its $20M ATM facility with Aspire Capital, while "not ideal," gives management a chance to execute on three of its ongoing programs, the most important of which is the dose escalation study with Olaparib with partner AstraZeneca (AZN) that should have preliminary data in 2Q17. The analyst raised his fair value estimate on Cerulean to $1.50 from $1.00 and keeps a Neutral rating on the stock.
10/26/16
LEER
10/26/16
NO CHANGE
Target $80
LEER
Market Perform
Novartis price target lowered to $80 from $89 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Novartis to $80 from $89 after a "disappointing" Q3 performance despite bottom-line beat. The analyst reiterates a Market Perform rating on the shares.
11/10/16
ARGS
11/10/16
UPGRADE
ARGS
Buy
Novartis upgraded to Buy from Hold at Argus
11/10/16
11/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Priceline (PCLN) upgraded to Buy from Hold at Stifel while the firm upgraded Expedia (EXPE) to Hold from Sell. 2. IBM (IBM) upgraded to Buy from Neutral at BofA/Merrill with analyst Wamsi Mohan expecting 2017 profits to grow as earnings have stabilized and negative revisions are unlikely and expects tailwinds from moderating pace of investments and savings from restructuring efforts. 3. L-3 Communications (LLL) and Northrop Grumman (NOC) upgraded to Overweight from Equal Weight at Barclays while the firm upgraded Lockheed Martin (LMT) to Equal Weight from Underweight. 4. Microsoft (MSFT) upgraded to Neutral from Underweight at Atlantic Equities. 5. Novartis (NVS) upgraded to Buy from Hold at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HIIQ

Health Insurance Innovations

$24.10

-1.35 (-5.30%)

, WLTW

Willis Towers Watson

$145.08

-0.28 (-0.19%)

08:22
06/27/17
06/27
08:22
06/27/17
08:22
Conference/Events
William Blair to hold a conference »

Benefits Brokerage &…

HIIQ

Health Insurance Innovations

$24.10

-1.35 (-5.30%)

WLTW

Willis Towers Watson

$145.08

-0.28 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

WING

Wingstop

$31.33

0.39 (1.26%)

08:22
06/27/17
06/27
08:22
06/27/17
08:22
Hot Stocks
Wingstop appoints CIO Stacy Peterson to new Chief Experience Officer role »

Wingstop has appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$18.70

-1 (-5.08%)

08:21
06/27/17
06/27
08:21
06/27/17
08:21
Technical Analysis
Technical View: Alder Biopharmaceuticals heads for 52-week low »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$1.94

0.03 (1.57%)

08:21
06/27/17
06/27
08:21
06/27/17
08:21
Initiation
Sunworks initiated  »

Sunworks initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGPI

MGP Ingredients

$49.51

-0.06 (-0.12%)

, CKH

Seacor

$32.30

-0.3 (-0.92%)

08:21
06/27/17
06/27
08:21
06/27/17
08:21
Hot Stocks
MGP Ingredients reaches agreement to sell stake in ICP JV »

MGP Ingredients (MGPI)…

MGPI

MGP Ingredients

$49.51

-0.06 (-0.12%)

CKH

Seacor

$32.30

-0.3 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

$DJT

DJ Transportation Average

08:21
06/27/17
06/27
08:21
06/27/17
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.95

0.34 (1.04%)

, XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Hot Stocks
Teva, Xenon says phase 2 study of topical TV-45070 did not meet primary endpoint »

Teva Pharmaceutical…

TEVA

Teva

$32.95

0.34 (1.04%)

XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

RICE

Rice Energy

$26.42

0.77 (3.00%)

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Downgrade
Rice Energy rating change  »

Rice Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$169.98

0.86 (0.51%)

08:20
06/27/17
06/27
08:20
06/27/17
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
06/27/17
06/27
08:20
06/27/17
08:20
General news
Fedspeak from Chair Yellen is atop the roster »

Fedspeak from Chair…

XLK

Technology Select Sector SPDR

$56.00

-0.3 (-0.53%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$64.24

-0.14 (-0.22%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

$89.84

0.32 (0.36%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$54.01

0.16 (0.30%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRX

Agile Therapeutics

$3.80

-0.04 (-1.04%)

08:19
06/27/17
06/27
08:19
06/27/17
08:19
Hot Stocks
Agile Therapeutics resubmits NDA for Twirla contraceptive patch »

Agile Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$53.57

0.36 (0.68%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$39.59

0.09 (0.23%)

, CHTR

Charter

$332.65

1.85 (0.56%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Technical View: Sprint rallies as it enters deal talks with Charter, Comcast »

The stock was last up…

CMCSA

Comcast

$39.59

0.09 (0.23%)

CHTR

Charter

$332.65

1.85 (0.56%)

S

Sprint

$8.01

-0.04 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 03

    Aug

XLP

Consumer Staples Sector SPDR

$55.71

0.22 (0.40%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$32.95

0.34 (1.04%)

, XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Hot Stocks
Breaking Hot Stocks news story on Teva, Xenon Pharmaceuticals »

Teva, Xenon says phase 2…

TEVA

Teva

$32.95

0.34 (1.04%)

XENE

Xenon Pharmaceuticals

$3.80

-0.3 (-7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

XLV

Health Care Select Sector SPDR

$80.39

-0.08 (-0.10%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$141.08

0.17 (0.12%)

08:18
06/27/17
06/27
08:18
06/27/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$213.87

0.13 (0.06%)

08:17
06/27/17
06/27
08:17
06/27/17
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.29

0.16 (0.07%)

08:17
06/27/17
06/27
08:17
06/27/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.